Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis-Reference-Cited by-同舟云学术

Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis

Published:2008-04-20 Issue:3 Volume:114 Page:423-431
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Habibi Mehran,Kmieciak Maciej,Graham Laura,Morales Johanna K.,Bear Harry D.,Manjili Masoud H.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-008-0024-3.pdf

Reference38 articles.

1. Jeffrey SS, Birdwell RL, Ikeda DM, Daniel BL, Nowels KW, Dirbas FM, Griffey SM (1999) Radiofrequency ablation of breast cancer: first report of an emerging technology. Arch Surg 134:1064–1068

2. Vlastos G, Verkooijen HM (2007) Minimally invasive approaches for diagnosis and treatment of early-stage breast cancer. The Oncologist 12:1–10

3. Zerbini A, Pilli M, Penna A, Pelosi G, Schianchi C, Molinari A et al (2006) Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66:1139–1146

4. den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ et al (2004) In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64:4024–4029

5. Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, Ames FC, Newman LA, Babiera GV, Singletary SE (2004) Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231:215–224

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruthenium Complex Suppresses Proliferation of Residual Hepatocellular Carcinoma after Incomplete Radiofrequency Ablation Therapy;Recent Patents on Anti-Cancer Drug Discovery;2024-08-12

2. Enhanced abscopal anti-tumor response via a triple combination of thermal ablation, IL-21, and PD-1 inhibition therapy;Cancer Immunology, Immunotherapy;2024-06-04

3. MDSCs in breast cancer: an important enabler of tumor progression and an emerging therapeutic target;Frontiers in Immunology;2023-07-03

4. Combining energy-based focal ablation and immune checkpoint inhibitors: preclinical research and clinical trials;Frontiers in Oncology;2023-05-01

5. Interventional Oncology and Immuno-Oncology: Current Challenges and Future Trends;International Journal of Molecular Sciences;2023-04-16